Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of highly-active antiretroviral therapy by race/ethnicity.
Silverberg MJ, Wegner SA, Milazzo MJ, McKaig RG, Williams CF, Agan BK, Armstrong AW, Gange SJ, Hawkes C, O'Connell RJ, Ahuja SK, Dolan MJ; Tri-Service AIDS Clinical Consortium Natural History Study Group. Silverberg MJ, et al. Among authors: agan bk. AIDS. 2006 Jul 13;20(11):1531-8. doi: 10.1097/01.aids.0000237369.41617.0f. AIDS. 2006. PMID: 16847408
Laboratory diagnosis of Bartonella infections.
Agan BK, Dolan MJ. Agan BK, et al. Clin Lab Med. 2002 Dec;22(4):937-62. doi: 10.1016/s0272-2712(02)00017-3. Clin Lab Med. 2002. PMID: 12489289 Review.
Unintended smallpox vaccination of HIV-1-infected individuals in the United States military.
Tasker SA, Schnepf GA, Lim M, Caraviello HE, Armstrong A, Bavaro M, Agan BK, Delmar J, Aronson N, Wallace MR, Grabenstein JD; US Department of Defense Tri-Service AIDS Clinical Consortium. Tasker SA, et al. Among authors: agan bk. Clin Infect Dis. 2004 May 1;38(9):1320-2. doi: 10.1086/420938. Epub 2004 Apr 14. Clin Infect Dis. 2004. PMID: 15127348
The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility.
Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley W, Clark RA, Anderson SA, O'connell RJ, Agan BK, Ahuja SS, Bologna R, Sen L, Dolan MJ, Ahuja SK. Gonzalez E, et al. Among authors: agan bk. Science. 2005 Mar 4;307(5714):1434-40. doi: 10.1126/science.1101160. Epub 2005 Jan 6. Science. 2005. PMID: 15637236
Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.
Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, Armstrong AW, Fraser S, Wallace MR; Triservice AIDS Clinical Consortium. Crum NF, et al. Among authors: agan bk. J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):194-200. doi: 10.1097/01.qai.0000179459.31562.16. J Acquir Immune Defic Syndr. 2006. PMID: 16394852
CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms.
Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, Anaya JM, Miura T, Hecht FM, Mamtani M, Pereyra F, Marconi V, Mangano A, Sen L, Bologna R, Clark RA, Anderson SA, Delmar J, O'Connell RJ, Lloyd A, Martin J, Ahuja SS, Agan BK, Walker BD, Deeks SG, Ahuja SK. Dolan MJ, et al. Among authors: agan bk. Nat Immunol. 2007 Dec;8(12):1324-36. doi: 10.1038/ni1521. Epub 2007 Oct 21. Nat Immunol. 2007. PMID: 17952079
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.
Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, O'Connell RJ, Marconi VC, Delmar J, Eron J, Clark RA, Frost S, Martin J, Ahuja SS, Deeks SG, Little S, Richman D, Hecht FM, Dolan MJ. Ahuja SK, et al. Among authors: agan bk. Nat Med. 2008 Apr;14(4):413-20. doi: 10.1038/nm1741. Epub 2008 Mar 30. Nat Med. 2008. PMID: 18376407 Free PMC article.
192 results